(Q38097280)

28 August 2017

title

Active surveillance of small renal masses. (English)

1 reference

28 August 2017

Marc C Smaldone

1

1 reference

28 August 2017

Anthony T Corcoran

series ordinal

2

1 reference

28 August 2017

Robert G Uzzo

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

9 April 2013

1 reference

28 August 2017

published in

Nature Reviews Urology

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

266-274

1 reference

28 August 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Rising incidence of renal cell cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Renal cell cancer stage migration: analysis of the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Increased incidence of serendipitously discovered renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Outcomes following partial nephrectomy by tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Guideline for management of the clinical T1 renal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Natural history of chronic renal insufficiency after partial and radical nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Renal and cardiovascular morbidity after partial or radical nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

EAU guidelines on renal cell carcinoma: the 2010 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Robot-assisted partial nephrectomy: a large single-institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Focal therapy for kidney cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Renal masses--to treat or not to treat? If that is the question are contemporary biomarkers the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Renal mass biopsy--a renaissance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Accuracy of percutaneous core biopsy in management of small renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Fine-needle percutaneous biopsy of renal masses with helical CT guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Pathologic concordance of sporadic synchronous bilateral renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Solid renal tumors: an analysis of pathological features related to tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Tumor size is associated with malignant potential in renal cell carcinoma cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Metastatic renal cell carcinoma risk according to tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Laparoscopic partial nephrectomy for renal masses: effect of tumor location

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Functional imaging of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Active surveillance of small renal masses: progression patterns of early stage kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Enhancing renal masses with zero net growth during active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Active surveillance for early-stage prostate cancer: review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Delayed intervention of sporadic renal masses undergoing active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

What is the best treatment strategy for incidentally detected small renal masses? A decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

The natural history of untreated renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Intraductal tumor involvement and renal parenchymal invasion of transitional cell carcinoma in the renal pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Active surveillance for selected patients with renal masses: updated results with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Conservative management of renal masses in the elderly: our experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Active surveillance of renal masses in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Observation should be considered as an alternative in management of renal masses in older and comorbid patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

21 January 2018

Overdiagnosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Approach to the small renal mass: to treat or not to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Rising incidence of small renal masses: a need to reassess treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Radical versus partial nephrectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

The impact of tumour location on the histological subtype of renal cortical tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

The natural history of incidentally detected small renal masses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Small renal parenchymal neoplasms: further observations on growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Growth rates of primary and metastatic lesions of renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Active surveillance for renal cortical neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.62

Estimated volume growth characteristics of renal tumors undergoing active surveillance.

31 March 2020

1 reference

12 December 2020

Trends in renal tumor surgery delivery within the United States

1 reference

12 December 2020

Growth characteristics of renal cortical tumors in patients managed by watchful waiting

1 reference

12 December 2020

Conservative management of small renal tumors

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2013.62

1 reference

Dimensions Publication ID

28 August 2017

1004310707

0 references

1 reference